비인두암 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Nasopharyngeal Cancer Treatment Market (Treatment Type: Radiation Therapy, Chemotherapy, Immunotherapy, and Others; End-user: Hospitals, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1402923
리서치사:Transparency Market Research
발행일:2023년 11월
페이지 정보:영문 203 Pages
라이선스 & 가격 (부가세 별도)
한글목차
비인두암 치료 시장 - 보고서의 범위
세계 비인두암 치료 시장에 대한 TMR의 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 전 세계 비인두암 치료 매출 정보를 제공합니다. 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017년부터 2031년까지 시장을 분석합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 비인두암 치료 시장의 복합 연간 성장률(CAGR%)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. KOL(Key Opinion Leader), 업계 리더 및 제조업체를 인터뷰하는 1차 조사 활동의 대부분을 분석가들이 수행했으며, 2차 조사에는 비인두암 치료 시장을 이해하기 위해 주요 업체의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조가 포함되었습니다.
시장 현황
2023년 시장 가치
5억 7,430만 달러
2031년 시장 가치
11억 달러
CAGR
7.3%
이 보고서는 세계 비인두암 치료 시장 경쟁 구도를 자세히 분석합니다. 세계 비인두암 치료 시장에서 활동하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성 측면에서 프로파일링되었습니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 비인두암 치료 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2023-2031년
제5장 주요 인사이트
병 역학
파이프라인 분석
상 인두 암 승인 의약품리스트
주요 업계 이벤트(제품 발매/합병, 인수, 제휴)
COVID-19 팬데믹이 업계에 미치는 영향
제6장 세계 시장 분석과 예측 : 치료 유형별
서론과 정의
주요 조사 결과/발전
시장가치와 양 예측 : 치료 유형별, 2023-2031
방사선 치료
화학요법
면역 치료
기타
시장의 매력 분석 : 치료 유형별
제7장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2023-2031
병원
전문 클리닉
기타
시장의 매력 분석 : 최종사용자별
제8장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제9장 북미 시장 분석과 예측
제10장 유럽 시장 분석과 예측
제11장 아시아태평양 시장 분석과 예측
제12장 라틴아메리카 시장 분석과 예측
제13장 중동 및 아프리카 시장 분석과 예측
제14장 경쟁 구도
시장 기업--경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Biocon Limited
BeiGene Ltd.
Shanghai Junshi Biosciences Co., Ltd.
Innogene Kalbiotech
Center of Molecular Immunology
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Biosyngen Pte. Ltd.
LSH
영문 목차
영문목차
Nasopharyngeal Cancer Treatment Market - Scope of Report
TMR's report on the global nasopharyngeal cancer treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal cancer treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal cancer treatment market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal cancer treatment market.
Market Snapshot
Market Value in 2023
US$ 574.3 Mn
Market Value in 2031
US$ 1.1 Bn
CAGR
7.3%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal cancer treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal cancer treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal cancer treatment market.
The report delves into the competitive landscape of the global nasopharyngeal cancer treatment market. Key players operating in the global nasopharyngeal cancer treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal cancer treatment market profiled in this report.
Key Questions Answered in Global nasopharyngeal cancer treatment Market Report:
What is the sales/revenue generated by nasopharyngeal cancer treatment across all regions during the forecast period?
What are the opportunities in the global nasopharyngeal cancer treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Nasopharyngeal Cancer Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global nasopharyngeal cancer treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global nasopharyngeal cancer treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal cancer treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasopharyngeal Cancer Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Disease Epidemiology
5.2. Pipeline Analysis
5.3. List of Drugs Approved for Nasopharyngeal Cancer
5.4. Key Industry Events (product launches/mergers, acquisitions & partnerships)
5.5. COVID-19 Pandemic Impact on Industry
6. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Treatment Type, 2023-2031
6.3.1. Radiation therapy
6.3.2. Chemotherapy
6.3.3. Immunotherapy
6.3.4. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023-2031
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Nasopharyngeal Cancer Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
9.2.1. Radiation therapy
9.2.2. Chemotherapy
9.2.3. Immunotherapy
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2023-2031
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2023-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Treatment Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Nasopharyngeal Cancer Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
10.2.1. Radiation therapy
10.2.2. Chemotherapy
10.2.3. Immunotherapy
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2023-2031
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Treatment Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Nasopharyngeal Cancer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
11.2.1. Radiation therapy
11.2.2. Chemotherapy
11.2.3. Immunotherapy
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2023-2031
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Treatment Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Nasopharyngeal Cancer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
12.2.1. Radiation therapy
12.2.2. Chemotherapy
12.2.3. Immunotherapy
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2023-2031
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Treatment Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Nasopharyngeal Cancer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
13.2.1. Radiation therapy
13.2.2. Chemotherapy
13.2.3. Immunotherapy
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2023-2031
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2023-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. Market Attractiveness Analysis
13.5.1. By Treatment Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Biocon Limited
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. BeiGene Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Shanghai Junshi Biosciences Co., Ltd.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Innogene Kalbiotech
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Center of Molecular Immunology
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Bristol-Myers Squibb Company
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Merck & Co., Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Biosyngen Pte. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
